Eurofins Scientific Sa (ERFSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 12-2024 | 06-2024 | 06-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 393,006 | 600,133 | 324,039 | 239,343 | 821,808 |
| Depreciation Amortization | 351,344 | 645,906 | 303,255 | 285,249 | 531,436 |
| Other Working Capital | -133,159 | 47,504 | -83,675 | -168,249 | 32,872 |
| Other Operating Activity | -13,736 | 133,639 | 27,461 | 6,869 | -188,910 |
| Operating Cash Flow | $597,456 | $1,427,182 | $571,080 | $363,212 | $1,197,206 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -3,633 | N/A | N/A | N/A | N/A |
| PPE Investments | -245,657 | -479,803 | -232,180 | -244,468 | -591,280 |
| Net Acquisitions | -179,589 | -372,567 | -264,917 | -81,889 | -226,208 |
| Purchase Sale Intangibles | -39,051 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -34,851 | -63,628 | -24,015 | -31,949 | -84,288 |
| Investing Cash Flow | $-463,729 | $-915,998 | $-521,112 | $-358,306 | $-901,776 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 759,335 | N/A | N/A | N/A | N/A |
| Debt Repayment | -134,181 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 423,543 | N/A | N/A | N/A | N/A |
| Common Stock Repurchased | -522,533 | N/A | N/A | N/A | N/A |
| Dividend Paid | -123,850 | -106,046 | -1,400 | N/A | 0 |
| Other Financing Activity | -338,063 | -1,072,902 | -631,925 | 223,423 | -327,986 |
| Financing Cash Flow | $64,252 | $-1,178,948 | $-633,325 | $223,423 | $-327,986 |
| Exchange Rate Effect | -41,548 | 10,172 | 1,292 | -12,103 | -843 |
| Beginning Cash Position | 696,105 | 1,321,136 | 1,314,787 | 526,881 | 542,604 |
| End Cash Position | 852,649 | 663,544 | 732,938 | 743,217 | 509,100 |
| Net Cash Flow | $156,544 | $-657,592 | $-581,849 | $216,335 | $-33,504 |
| Free Cash Flow | |||||
| Operating Cash Flow | 597,456 | 1,427,182 | 571,080 | 363,212 | 1,197,206 |
| Capital Expenditure | -251,220 | N/A | N/A | N/A | N/A |
| Free Cash Flow | 346,236 | 1,427,182 | 571,080 | 363,212 | 1,197,206 |